Methodological Considerations in Interpreting IL-15 Plus Thymosin alpha1 Therapy for Hepatocellular Carcinoma. Kumar S, Shaikh MM. J Gastroenterol Hepatol 2026 Jul 17. doi: 10.1111/jgh.70607.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kumar S, Shaikh MM. Methodological Considerations in Interpreting IL-15 Plus Thymosin alpha1 Therapy for Hepatocellular Carcinoma. J Gastroenterol Hepatol 2026 Jul 17. doi: 10.1111/jgh.70607.
PMID: 42464890